The Speakers & Panelists Shared their experience :
Country experience of PPH management; Gaps in knowledge and practices; Documentation challenges; Availability of Drugs; PPH bundle approach management; Availability of Blood and Blood Components; Experiences in public and private sectors in your country; Additional steps needed to reduce PPH in country; Referral Linkages

Prof Rohana (President SAFOG) gave the overview of the Webinar
Prof Arulkumaran shared his experience, recommendations and way forward in the end
3 important committees for any trial are : Steering committee, Data monitoring committee & Publication committee
Audit is very important as well as Champions of the Trial

Prof Lumaan Shaikh (AKUH, Pakistan) shared details about the ongoing EMOTIVE Trial
PPH is often not detected early; thus life-saving treatment is not promptly initiated  Solution: Early detection and treatment of PPH. Several approaches can be used to increase the accuracy of visual evaluation of blood volume. Deaths were reduced – Trenexamic Acid should be given in <3 hours of PPH

It is of benefit whether atonic or bleeding from trauma. Survival benefit decreased by 10% for every 15 min delay until 3 h, after which there was no benefit
Care Bundle Approach of first response together rather than sequential, & application of management modalities

The E-MOTIVE trial is the Early detection of PPH & treatment using the WHO MOTIVE 'first response' bundle: a cluster randomized trial with health economic analysis and mixed methods evaluation